Fujifilm has purchased Merck's contract manufacturing sites for biologics in North Carolina and in Northeast England for $490 M.
Fujifilm acquires Merck Biomanufacturing Network.
Fuji says the acquisition will enhance its pharma group profile - an area it is trying to build as it diversifies its holdings away from the shrinking photo paper business. Fierce Biotech notes that it is ironic that Fuji views pharma as an atttractive diversification at a time when many Big Pharma companies are diversifiying into other industries like animal health, consumer products and the like.
Maybe the grass is greener looking through the eye of a digital camera?
Posted by Bruce Lehr March 2nd 2011.
Dear Editor
Fujilfilm Diosynth Biotechnologies (formerly Merck Biomanufacturing Network) website moves to new domain at:
http://www.fujifilmdiosynth.com
Following the acquisition in March this year of Merck’s BioManufacturing Network by Fujifilm Corporation to create Fujifilm Diosynth Biotechnologies the company website domain has also changed to this new address.
As one of the world’s leading contract manufacturing organisations Fujilfilm Diosynth Biotechnologies would be grateful if you could bring this new domain to the attention of your readers and if you have a link to the old address listed on your website we would be grateful if you could change it to the new address.
If you have any questions about this please contact me.
Kind regards
Emily Blythe.
Posted by: Emily Blythe | 06/23/2011 at 05:28 AM